Entry Detail



General Information

Database ID:exR0363341
RNA Name:FLNA
RNA Type:mRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):154348524End Site(bp):154374638
External Links:ENSG00000196924



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AATF
chr17
36948954
37056871
+
ABCA2
chr9
137007234
137028922
-
ABHD17A
chr19
1876810
1885547
-
AC008403.1
chr19
48465837
48472431
+
AC008982.1
chr19
38817471
38840178
-
AC027644.4
chr7
66628958
66811189
+
AC138969.1
chr16
16317444
16350590
+
AC233992.2
chr8
144353228
144355609
-
AC245033.1
chr15
82536788
82573194
-
ACIN1
chr14
23058564
23095614
-
ACTB
chr7
5527148
5563784
-
ADAMTS1
chr21
26835755
26845409
-
ADAMTS19
chr5
129460281
129738683
+
ADAMTSL4
chr1
150549369
150560937
+
ADCY3
chr2
24819169
24919839
-
ADCY6
chr12
48766194
48789037
-
ADGRE5
chr19
14380501
14408725
+
ADIPOR1
chr1
202940826
202958572
-
ADNP2
chr18
80109262
80147523
+
AFDN
chr6
167826922
167972023
+
AFG3L2
chr18
12328944
12377227
-
AFMID
chr17
78187317
78207701
+
AGO2
chr8
140520156
140635633
-
AGPAT1
chr6
32168212
32178096
-
AGRN
chr1
1020120
1056118
+
AIP
chr11
67483026
67491103
+
AK4
chr1
65147549
65232145
+
AKT2
chr19
40230317
40285536
-
AL807752.6
chr9
137031241
137040436
-
ALDH7A1
chr5
126531200
126595362
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-103a-3p
chr5
168560904
168560926
-
hsa-miR-5100
chr10
42997630
42997651
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC015961.2
chr18
37243776
37247506
+
AC026362.1
chr12
122975320
122982907
+
AC079781.5
chr7
97851688
97972985
-
AD000090.1
chr19
35557956
35581954
+
AL021707.2
chr22
38667585
38681847
-
AL137127.1
chr1
19072110
19075511
-
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.